Cancers With NTRK, ROS1, or ALK Gene Fusions
1 clinical trials · Condition
◉ Watch Cancers With NTRK, ROS1, or ALK Gene Fusions
| Record | Firm | Date |
|---|---|---|
| Expanded Access to Entrectinib for Cancers With NTRK1/2/3, ROS1, or ALK Gene Fusions (NCT03066661) | Hoffmann-La Roche |
Track Cancers With NTRK, ROS1, or ALK Gene Fusions automatically
Every clearance here is in the API, with alerts when new ones post.